Patents by Inventor Cherry Wongtrakool

Cherry Wongtrakool has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders
    Publication number: 20250276002
    Abstract: This disclosure relates to nucleobase polymers useful for degrading GATA-3 mRNA. In certain embodiments, this disclosure relates to nucleobase polymers and nanoparticles conjugated to nucleobase polymers disclosed herein. In certain embodiments, the nucleobase polymers or nanoparticles can be used in methods of managing disorders associated with excessive GATA-3 expression in inflammatory disorders and respiratory disorders such as asthma.
    Type: Application
    Filed: May 19, 2025
    Publication date: September 4, 2025
    Inventors: Khalid Salaita, Cherry Wongtrakool, Kornelia Galior
  • Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders
    Publication number: 20210093655
    Abstract: This disclosure relates to nucleobase polymers useful for degrading GATA-3 mRNA. In certain embodiments, this disclosure relates to nucleobase polymers and nanoparticles conjugated to nucleobase polymers disclosed herein. In certain embodiments, the nucleobase polymers or nanoparticles can be used in methods of managing disorders associated with excessive GATA-3 expression in inflammatory disorders and respiratory disorders such as asthma.
    Type: Application
    Filed: December 15, 2020
    Publication date: April 1, 2021
    Inventors: Khalid Salaita, Cherry Wongtrakool, Kornelia Galior
  • Particles with RNA cleaving nucleobase polymers and uses for managing inflammatory disorders
    Patent number: 10905710
    Abstract: This disclosure relates to nucleobase polymers useful for degrading GATA-3 mRNA. In certain embodiments, this disclosure relates to nucleobase polymers and nanoparticles conjugated to nucleobase polymers disclosed herein. In certain embodiments, the nucleobase polymers or nanoparticles can be used in methods of managing disorders associated with excessive GATA-3 expression in inflammatory disorders and respiratory disorders such as asthma.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: February 2, 2021
    Assignees: Emory University, The United States Government as represented by the Department of Veterans Affairs
    Inventors: Khalid Salaita, Cherry Wongtrakool, Kornelia Galior
  • Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders
    Publication number: 20190192550
    Abstract: This disclosure relates to nucleobase polymers useful for degrading GATA-3 mRNA. In certain embodiments, this disclosure relates to nucleobase polymers and nanoparticles conjugated to nucleobase polymers disclosed herein. In certain embodiments, the nucleobase polymers or nanoparticles can be used in methods of managing disorders associated with excessive GATA-3 expression in inflammatory disorders and respiratory disorders such as asthma.
    Type: Application
    Filed: May 24, 2017
    Publication date: June 27, 2019
    Inventors: Khalid Salaita, Cherry Wongtrakool, Kornelia Galior